Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK1D | P48730 | 3/20 | 0.60 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.60 |
| ▸ | SLC6A7 | Q99884 | 5/20 | 0.51 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | DRD2 | P14416 | 2/20 | 0.41 |
| ▸ | DRD4 | P21917 | 2/20 | 0.41 |
| ▸ | DRD3 | P35462 | 2/20 | 0.41 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1753099 | 1.00 | CSNK1D (0.60) | CSNK1DMAPK14SLC6A7MAPTLMNA | |
| Tt-301 SCHEMBL529453 | 0.99 | CSNK1D (0.59) | CSNK1DMAPK14SLC6A7MAPTLMNA | |
| Tt-301 SCHEMBL9998818 | 0.99 | CSNK1D (0.59) | CSNK1DMAPK14SLC6A7MAPTLMNA | |
| Tt-301 SCHEMBL300506 | 0.99 | CSNK1D (0.59) | CSNK1DMAPK14SLC6A7MAPTLMNA | |
| SCHEMBL29572108 | 0.95 | SLC6A7 (0.56) | CSNK1DMAPK14SLC6A7MAPTLMNA | |
| SCHEMBL720267 | 0.95 | SLC6A7 (0.56) | CSNK1DMAPK14SLC6A7MAPTLMNA | |
| SCHEMBL14679251 | 0.87 | LMNA (0.56) | CSNK1DMAPK14SLC6A7MAPTLMNA | |
| SCHEMBL1753062 | 0.87 | SLC6A7 (0.49) | CSNK1DMAPK14SLC6A7MAPTLMNA | |
| SCHEMBL1753146 | 0.87 | CSNK1D (0.46) | CSNK1DMAPK14SLC6A7MAPTLMNA | |
| SCHEMBL5005886 | 0.87 | DRD2 (0.49) | CSNK1DMAPK14SLC6A7MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250195517-A1 | TREATMENT OF INTRACRANIAL HEMORRHAGE | IMMUNOCHEM THERAPEUTICS, LLC | 2025-06-19 | — | — | US | claimed |
| EP-4482495-A1 | TREATMENT OF INTRACRANIAL HEMORRHAGE | Immunochem Therapeutics, LLC (US) | 2025-01-01 | — | — | EP | claimed |
| WO-2023163951-A1 | TREATMENT OF INTRACRANIAL HEMORRHAGE | IMMUNOCHEM THERAPEUTICS, LLC (US) | 2023-08-31 | — | — | WO | claimed |
| CN-114654615-A | High-speed mixing control device and control method | 康辉新材料科技有限公司 | 2022-06-24 | — | — | CN | claimed |
| WO-2012012890-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT OF ARTHRITIS | WARATAH PHARMACEUTICALS INC. (CA) | 2012-02-02 | — | — | WO | claimed |
| WO-2011156900-A2 | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT OF MULTIPLE SCLEROSIS | WARATAH PHARMACEUTICALS INC. (CA) | 2011-12-22 | — | — | WO | claimed |
| WO-2011137511-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM INJURIES | WARATAH PHARMACEUTICALS INC. (CA) | 2011-11-10 | — | — | WO | claimed |
| US-20260144674-A1 | Apparatus and Methods for Drug Delivery Using Microneedles | CLEARSIDE BIOMEDICAL, INC. (US) | 2026-05-28 | — | — | US | disclosed |
| EP-4058037-B1 | FIBROBLAST-BASED THERAPY FOR TREATMENT AND PREVENTION OF STROKE | SPINALCYTE LLC (US) | 2026-01-28 | — | — | EP | disclosed |
| US-20250345206-A1 | APPARATUS AND METHODS FOR OCULAR INJECTION | CLEARSIDE BIOMEDICAL, INC. (US) | 2025-11-13 | — | — | US | disclosed |
| US-12350261-B2 | Methods and devices for the treatment of ocular diseases in human subjects | CLEARSIDE BIOMEDICAL, INC. (US) | 2025-07-08 | — | — | US | disclosed |
| US-20250195517-A1 | TREATMENT OF INTRACRANIAL HEMORRHAGE | IMMUNOCHEM THERAPEUTICS, LLC | 2025-06-19 | — | — | US | disclosed |
| US-20250186253-A1 | DEVICES AND METHODS FOR ADJUSTING THE INSERTION DEPTH OF A NEEDLE FOR MEDICAMENT DELIVERY | CLEARSIDE BIOMEDICAL, INC. (US) | 2025-06-12 | — | — | US | disclosed |
| US-20080318899-A1 | Pyridazine Compounds, Compositions and Methods | UNIVERSITE DE STRASBOURG (FR) | 2008-12-25 | — | — | US | disclosed |
| WO-2007130383-A2 | COMPOSITIONS AND TREATMENTS USING PYRIDAZINE COMPOUNDS AND SECRETASES | NORTHWESTERN UNIVERSITY (US) | 2007-11-15 | — | — | WO | disclosed |
| WO-2007127475-A2 | PYRIDAZINES FOR DEMYELINATING DISEASES AND NEUROPATHIC PAIN | NORTHWESTERN UNIVERSITY (US) | 2007-11-08 | — | — | WO | disclosed |
| WO-2007127375-A2 | FORMULATIONS CONTAINING PYRIDAZINE COMPOUNDS FOR TREATING NEUROINFLAMMATORY DISEASES | NORTHWESTERN UNIVERSITY (US) | 2007-11-08 | — | — | WO | disclosed |
| WO-2007127474-A2 | COMPOSITIONS AND TREATMENTS USING PYRIDAZINE COMPOUNDS AND CHOLINESTERASE INHIBITORS | NORTHWESTERN UNIVERSITY (US) | 2007-11-08 | — | — | WO | disclosed |
| EP-1812408-A2 | PYRIDAZINE COMPOUNDS, COMPOSITIONS AND METHODS | Northwestern University (US) | 2007-08-01 | — | — | EP | disclosed |
| WO-2006050389-A2 | PYRIDAZINE COMPOUNDS, COMPOSITIONS AND METHODS | NORTHWESTERN UNIVERSITY (US) | 2006-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260144674-A1 | Apparatus and Methods for Drug Delivery Using Microneedles | PROKR2, SLC10A2, GLP1R | CSNK1D 1998/4885MAPK14 735/4885SLC6A7 412/4885 |
| US-20080318899-A1 | Pyridazine Compounds, Compositions and Methods | APP, PSEN1, PSEN2 | CSNK1D 1547/4885MAPK14 126/4885SLC6A7 3890/4885 |
| US-20250195517-A1 | TREATMENT OF INTRACRANIAL HEMORRHAGE | FABP7, PROC, PLG | CSNK1D 2450/4885MAPK14 4681/4885SLC6A7 2935/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.